上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
Estriol (Synonyms: 雌三醇; Oestriol) 纯度: 99.27%
Estriol是G蛋白偶联雌激素受体拮抗剂,可作用于雌激素受体阴性乳腺癌细胞。
Estriol Chemical Structure
CAS No. : 50-27-1
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | Apply now | ||
10 mM * 1 mL in DMSO | ¥500 | In-stock | |
100 mg | ¥450 | In-stock | |
500 mg | ¥850 | In-stock | |
1 g | 询价 | ||
5 g | 询价 |
* Please select Quantity before adding items.
Estriol 相关产品
•相关化合物库:
- Natural Product Library Plus
- Drug Repurposing Compound Library Plus
- FDA-Approved Drug Library Plus
- FDA-Approved Drug Library Mini
- Bioactive Compound Library Plus
- Metabolism/Protease Compound Library
- Natural Product Library
- FDA-Approved Drug Library
- Anti-Cancer Compound Library
- Human Endogenous Metabolite Compound Library
- Drug Repurposing Compound Library
- Lipid Compound Library
- Anti-COVID-19 Compound Library
- NMPA-Approved Drug Library
- Phenols Library
- Orally Active Compound Library
- Traditional Chinese Medicine Monomer Library
- FDA Approved & Pharmacopeial Drug Library
- Anti-Alzheimer’s Disease Compound Library
- Anti-Breast Cancer Compound Library
- Food-Sourced Compound Library
- Rare Diseases Drug Library
生物活性 |
Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells. Target: Estrogen Receptor/ERR A recent study shows that estrogen (estrone, estradiol, and estriol) inhibits Alzheimer’s disease-associated low-order Aβ oligomer formation, and among them, estriol shows the strongest in vitro activity [1]. In mPTEN+/- mice, estriol treatments resulted in a 187.54% gain in the relative ratio of uterine wet weight to body weight; estriol also increases the ratio to 176.88% in wild-type mice [2]. Estriol treatment (20 mg/kg ip), in vivo, sensitizes Kupffer cells to LPS via mechanisms dependent on an increase in CD14 by elevated portal blood endotoxin caused by increased gut permeability in rats; while one-half of the rats given estriol intraperitoneally 24 hours before an injection of a sublethal dose of LPS (5 mg/kg) died within 24 hours [3]. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
288.38 |
||||||||||||||||
Formula |
C18H24O3 |
||||||||||||||||
CAS 号 |
50-27-1 |
||||||||||||||||
中文名称 |
雌三醇 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
|
||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 250 mg/mL (866.91 mM; Need ultrasonic) H2O : 1 mg/mL (3.47 mM; ultrasonic and warming and heat to 80°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
|
||||||||||||||||
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务